Lacrimal canaliculus obstruction: nonsurgical treatment with a newly designed polyurethane stent.
H Y Song, C O Lee, Sung Hun Park, Seung Woo Suh, Hyun‐Ki Yoon, Sook‐Kyoung Kang, Kyu‐Bo Sung
Abstract
H Y Song, C O Lee, Sung Hun Park, Seung Woo Suh, Hyun‐Ki Yoon, Sook‐Kyoung Kang, Kyu‐Bo Sung
Abstract
A newly designed polyurethane stent was used to successfully treat 30 eyes (in 28 patients) with epiphora resulting from obstruction of the lacrimal canaliculus. After stent placement, epiphora resolved in all eyes. During follow-up, epiphora recurred in 20 eyes, but epiphora did not recur and the lacrimal canaliculus was patent in 12 eyes after the stent was removed. The stent appears to be valuable for nonsurgical treatment of obstruction of the lacrimal canaliculus.
OpenAlex reports 22 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A newly designed polyurethane stent was used to successfully treat 30 eyes (in 28 patients) with epiphora resulting from obstruction of the lacrimal canaliculus. After stent placement, epiphora resolved in all eyes. During follow-up, epiphora recurred in 20 eyes, but epiphora did not recur and the lacrimal canaliculus was patent in 12 eyes after the stent was removed. The stent appears to be valuable for nonsurgical treatment of obstruction of the lacrimal canaliculus.
Key concepts: Medicine, Lacrimal canaliculi, Stent, Surgery, Dacryocystorhinostomy, Lacrimal apparatus, Bone canaliculus, Lacrimal sac